Cargando…
Cost-effectiveness model for a hypothetical monotherapy vs standard of care in adult patients with treatment-resistant depression
BACKGROUND: Patients with treatment-resistant major depressive disorder (TRD) have limited treatment options. We developed an early stage cost-effectiveness model of TRD to explore the potential value of a hypothetical monotherapy relative to the standard of care (SOC). The relative impacts of the m...
Autores principales: | Wang, Si-Tien, Anderson, Ian M, Mitchell, Dominic, Johnson, Scott J, Shiozawa, Aki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421973/ https://www.ncbi.nlm.nih.gov/pubmed/30936731 http://dx.doi.org/10.2147/CEOR.S181718 |
Ejemplares similares
-
Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastoma
por: Gleeson, Jack Patrick, et al.
Publicado: (2019) -
Differential neural circuitry and self-interest in real vs
hypothetical moral decisions
por: FeldmanHall, Oriel, et al.
Publicado: (2012) -
The Hypothetical Rabbit
por: Kattan, Michael W.
Publicado: (2016) -
Cost-containment protocols for prostate core needle biopsies: hypothetical scenarios to reduce procedural costs
por: Ruiz-Cordero, Roberto, et al.
Publicado: (2019) -
Characterization of Cercospora nicotianae Hypothetical Proteins in Cercosporin Resistance
por: Beseli, Aydin, et al.
Publicado: (2015)